Iridex CORP Form 4 insider transactions

NASDAQ
IRIDEX Corp. President and CEO Patrick Mercer reported an exempt disposition of 4,243 common shares to satisfy tax withholding obligations related to restricted stock units, maintaining a beneficial ownership of 415,857 shares.
NASDAQ
IRIDEX Corp. Director Scott Shuda has filed an amended Form 4, disclosing the acquisition of 53,000 stock options with an exercise price of $0.94, granted under the company's 2008 Equity Incentive Plan.
NASDAQ
IRIDEX Corp. Director Beverly A. Huss was granted 53,000 stock options with an exercise price of $0.94 per share, vesting over the next year.
NASDAQ
IRIDEX Corp. Director Yu-Hao Chen was granted a total of 68,000 stock options with an exercise price of $0.94 per share, vesting over various schedules.
NASDAQ
IRIDEX Corp. Director William M. Moore was granted new stock options for a total of 68,000 shares of common stock at an exercise price of $0.94 per share, aligning his interests with long-term company performance.
NASDAQ
IRIDEX Corp's Chief Financial Officer, Romeo R. Dizon, has reported the acquisition of 22,500 Restricted Stock Units and 75,000 stock options, aligning his compensation with the company's future performance.
NASDAQ
IRIDEX Corp's President and CEO, Patrick Mercer, filed an amended Form 4 detailing the acquisition of 33,370 restricted stock units and 111,240 stock options, both granted at an exercise price of $0.94 per share.
NASDAQ
IRIDEX Corporation's Chief Financial Officer, Romeo R. Dizon, has increased his beneficial ownership in the company through the acquisition of 22,500 Restricted Stock Units and 75,000 stock options.
NASDAQ
IRIDEX Corp's President and CEO, Patrick Mercer, was granted 33,370 restricted stock units and options to purchase 111,240 shares of common stock, aligning his compensation with shareholder interests.
NASDAQ
IRIDEX Corporation's Director Beverly Huss was granted 53,000 stock options with a $1.4 exercise price, vesting over one year or by the 2026 Annual Meeting.
NASDAQ
IRIDEX Corp. Director Scott Shuda was granted 53,000 derivative securities, specifically stock options, with vesting commencing on June 13, 2025.
NASDAQ
IRIDEX Corp. Director William M. Moore has increased his direct beneficial ownership by purchasing 20,000 shares of common stock at a weighted average price of $0.9686 per share.
NASDAQ
IRIDEX Corp. President and CEO Patrick Mercer acquired 250 shares of common stock at $0.96 per share, increasing his direct beneficial ownership to 386,730 shares.
NASDAQ
IRIDEX Corp. Director William M. Moore has increased his direct beneficial ownership in the company by acquiring 30,000 shares of common stock across two transactions in mid-June 2025.
NASDAQ
IRIDEX Corp.'s Chief Financial Officer, Romeo Dizon, has acquired an additional 245 shares of common stock, increasing his direct beneficial ownership in the company.
NASDAQ
IRIDEX Corporation's Chief Financial Officer, Romeo Dizon, has increased his direct beneficial ownership in the company through two open market purchases of common stock in early June 2025.
NASDAQ
IRIDEX Corp.'s Chief Financial Officer, Romeo R. Dizon, acquired 1,500 shares of the company's common stock at $0.97 per share, increasing his total beneficial ownership to 14,165 shares.
NASDAQ
IRIDEX Corporation's Chief Financial Officer, Romeo R. Dizon, has reported two recent open market purchases of the company's common stock, increasing his direct beneficial ownership.
NASDAQ
IRIDEX Corporation's Chief Financial Officer, Romeo Dizon, has acquired an additional 200 shares of common stock, signaling increased insider confidence.
NASDAQ
IRIDEX Chief Financial Officer Romeo Dizon has acquired 200 shares of common stock at $0.95 per share, increasing his beneficial ownership to 12,265 shares.
NASDAQ
IRIDEX Corp's Chief Financial Officer, Romeo Dizon, has acquired 100 shares of common stock, increasing his direct beneficial ownership in the company.
NASDAQ
IRIDEX Corp. President and CEO Patrick Mercer reported the withholding of 14,310 shares of common stock to cover tax obligations related to the net settlement of restricted stock units.
NASDAQ
IRIDEX Corp.'s Chief Financial Officer, Romeo R. Dizon, has purchased 100 shares of the company's common stock, increasing his beneficial ownership.
NASDAQ
Romeo R. Dizon, CFO of Iridex Corp, reports purchasing 200 shares of common stock on May 22, 2025.
NASDAQ
Director William M. Moore reports purchasing additional shares of Iridex Corp, increasing his direct and indirect holdings.
NASDAQ
Romeo Dizon, CFO of Iridex Corp, reports the acquisition of 460 shares of common stock at $1.1 per share.
NASDAQ
Romeo R. Dizon, CFO of Iridex Corp, reports purchasing common stock in three transactions on May 13, 2025.
NASDAQ
Chief Financial Officer of Iridex Corp, Romeo Dizon, reports the acquisition of 100 shares of common stock at $1.16 per share on May 12, 2025.
NASDAQ
Chief Financial Officer of Iridex Corp, Romeo Dizon, reports the acquisition of 100 shares of common stock at $1.15 per share on May 9, 2025.
NASDAQ
Romeo R. Dizon, CFO of Iridex Corp, reports the acquisition of 100 shares of common stock at $1.15 per share on May 8, 2025.